Rare Disease Endpoint Advancement Pilot Program Grant Status: ACTIVE Funder: Amyotrophic Lateral Sclerosis Association (ALS) Last Updated: February 19, 2026 Summary The Rare Disease Endpoint Advancement Pilot Program, initiated by the FDA, aims to enhance the …
Sign in to start building your grant-ready profile
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.